Benzinga | Nov 5, 2020 07:26AM EST

EyePoint Pharmaceuticals Q1 EPS $(0.03) Beats $(0.05) Estimate, Sales $15.70M Beat $10.54M Estimate

EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 80 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $15.70 million which beat the analyst consensus estimate of $10.54 million by 48.91 percent. This is a 525.55 percent increase over sales of $2.51 million the same period last year.